Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Valeritas Holdings, Inc. (OTC: VLRX).

Full DD Report for VLRX

You must become a subscriber to view this report.


Recent News from (OTC: VLRX)

Valeritas' V-Go insulin delivery device launched in Australia
Valeritas Holdings (NASDAQ: VLRX )  announces that V-Go has launched and is now available in Australia through its exclusive distribution agreement with AMSL Diabetes. More news on: Valeritas Holdings, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: August, 23 2018 08:37
Valeritas Announces that V-Go® Insulin Delivery Device Has Launched in Australia
BRIDGEWATER, N.J., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , a simple, affordable, all-in-one insulin delivery option that is worn like a patch for patients with diabe...
Source: GlobeNewswire
Date: August, 23 2018 07:00
Valeritas Holdings, Inc. (VLRX) CEO John Timberlake on Q2 2018 Results - Earnings Call Transcript
Valeritas Holdings, Inc. (VLRX) Q2 2018 Earnings Conference Call August 7, 2018 4:30 P.M. ET Executives Greg Chodaczek - Investor Relations, Gilmartin Group John Timberlake - President and Chief Executive Officer Erick Lucera - Chief Financial Officer Analysts Ryan Blicker ...
Source: SeekingAlpha
Date: August, 07 2018 20:34
Valeritas beats by $0.11, beats on revenue
Valeritas (NASDAQ: VLRX ): Q2 EPS of -$0.62 beats by $0.11 . More news on: Valeritas Holdings, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: August, 07 2018 16:42
Valeritas Reports Record Second Quarter Revenue with 36% Year-over-Year Growth
BRIDGEWATER, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device , a simple, affordable, all-in-one, insulin delivery option that is worn like a patch for patients with diabet...
Source: GlobeNewswire
Date: August, 07 2018 16:05
Valeritas Announces V-Go® Distribution Agreement in Czech Republic and Slovakia
BRIDGEWATER, N.J., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced that it...
Source: GlobeNewswire
Date: August, 06 2018 07:00
Valeritas' V-Go® Wearable Insulin Delivery Device Demonstrated Improved Clinical Benefits in Patients with Uncontrolled Type 2 Diabetes Previously Treated with Multiple Daily Injections
BRIDGEWATER, N.J., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device , a simple, all-in-one, wearable insulin delivery option for patients with diabetes, announced today a poster ...
Source: GlobeNewswire
Date: August, 02 2018 07:00
Valeritas Announces that V-Go® Insulin Delivery is Now Available in New Zealand
BRIDGEWATER, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced V-Go is now ...
Source: GlobeNewswire
Date: August, 01 2018 07:00
Free Pre-Market Technical Recap on DENTSPLY SIRONA and Three Additional Medical Supplies Stocks
Stock Research Monitor: ELGX, GKOS, and VLRX LONDON, UK / ACCESSWIRE / July 31, 2018/ If you want a free Stock Review on XRAY sign up now at www.wallstequities.com/registration . On Monday, July 30, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edge...
Source: ACCESSWIRE IA
Date: July, 31 2018 07:31
Valeritas, Makers of V-Go® Insulin Delivery, is a Contributing Supporter of the Interactive Insulin Workshop at Two MEDS Conferences
BRIDGEWATER, N.J., July 25, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device for patients with diabetes, today announced their support of the interactive insulin workshops at the upcoming...
Source: GlobeNewswire
Date: July, 25 2018 07:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-140.400.37440.40690.371,370,531
2018-12-130.380.36260.3890.36821,611
2018-12-120.36950.36990.3950.35011,751,194
2018-12-110.370.37320.380.361,126,754
2018-12-100.33060.36890.37980.32011,449,942

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2017-03-141,1001,45475.6534Short
2017-03-133,7004,30086.0465Short
2017-03-103,4003,90087.1795Short
2017-03-099005,10017.6471Cover
2017-02-071,0001,90052.6316Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on VLRX.


About Valeritas Holdings, Inc. (OTC: VLRX)

Logo for Valeritas Holdings, Inc. (OTC: VLRX)

Valeritas is a commercial stage medical technology company focused on developing innovative technologies to improve the health and quality of life of people with Type diabetes. Valeritas flagship product, V Go Disposable Insulin Delivery device, is a simple, wearable, basal bolus insulin delivery solution for patients with Type diabetes that enables patients to administer a continuous preset basal rate of insulin over hours. It also provides on demand bolus dosing at mealtimes. It is the only basal bolus insulin delivery device on the market today specifically designed keeping in mind the needs of type diabetes patients. Headquartered in Bridgewater, New Jersey, Valeritas operates its R amp D functions in a state of the art facility in Shrewsbury, Massachusetts. For more information, please visit www.valeritas.com.

 

Contact Information

 

 

Current Management

  • John Timberlake / CEO, Chief Commercial Officer, President
  • Erick Lucera / CFO
  • Mark Conley / Vice President, Corporate Controller, Treasurer
  • Brian Johnston / IR Analyst
  • Rodney Altman / Independent Director
  • Katherine D. Crothall /
  • Peter Devlin / Independent Director
  • Luke Duster /
  • Joe Mandato /
  • Brian K Roberts /
  • John Timberlake /

Current Share Structure

  • Market Cap: $21,023,346 - 03/20/2018
  • Authorized: 300,000,000 - 06/30/2017
  • Issue and Outstanding: 7,007,782 - 02/26/2018

 


Recent Filings from (OTC: VLRX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 09 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: April, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 27 2018
Prospectus filed under Rule 424(b)(4)
Filing Type: 424B4Filing Source: edgar
Filing Date: April, 25 2018
Registration of up to an additional 20% of securities for any offering registered on an S-1
Filing Type: S-1MEFFiling Source: edgar
Filing Date: April, 23 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: April, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 20 2018

 

 


Daily Technical Chart for (OTC: VLRX)

Daily Technical Chart for (OTC: VLRX)


Stay tuned for daily updates and more on (OTC: VLRX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: VLRX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in VLRX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of VLRX and does not buy, sell, or trade any shares of VLRX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/